Bene Vobis MCT oil from coconut 500 ml

The dietary supplement Bene Vobis Coconut MCT Oil is a high-quality product that contains valuable MCT oil from the coconut. This oil is a treasure trove of many active ingredients with health-promoting properties, such as caproic, caprylic, capric, lauric, myristic, and palmitic acids. The product from Bene Vobis has a simple composition, without any additives, preservatives, flavor enhancers, or colorants.

MCTs are medium-chain saturated fats consisting of 6-10 carbon atoms. They are mainly found in the coconut palm. These fats are metabolized in the liver and not absorbed in the intestine like other fats.

The caprylic acid contained in MCTs can help reduce the feeling of hunger. It is involved in the acylation of ghrelin, which is widely known as the hunger hormone due to its orexigenic effect. [1]

Medium-chain fatty acids contribute to lowering LDL levels and increasing HDL levels. This effect has been shown to be comparable to that of olive oil. [2]

MCT supplementation can improve cognitive functions. Caprylic acid has been shown to help restore cognitive function in individuals who have experienced cognitive decline. [3]

In summary, Bene Vobis Coconut MCT Oil is a high-quality product that provides valuable MCT oil from the coconut. This substance has many health benefits. The product from Bene Vobis has the advantage of a pure, simple composition without any additives and a liquid form that is convenient to use.

1 Lemarié F, Beauchamp E, Legrand P, Rioux V. Review of the metabolism and physiological functions of caprylic acid (C8:0) with special emphasis on the acylation of ghrelin. Biochimie. 2016 Jan;120:40-8. doi: 10.1016/j.biochi.2015.08.002. Epub 2015 Aug 4. PMID: 26253695.

2 St-Onge MP, Bosarge A, Goree LL, Darnell B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52. doi: 10.1080/07315724.2008.10719737. PMID: 18845704; PMCID: PMC2874191.

3 Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter study. Nutr Metab (London). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31. PMID: 19664276; PMCID: PMC2731764.